Loading...
Docoh

Coeptis Therapeutics (COEP)

45 filings

Newest first
Filter options loading...
Top filers
Top filing types
Recent filing years
8-K
COEP Coeptis Therapeutics Inc.
17 May 22
Option agreement comprises three technologies and associated patent portfolios
5:01pm
DEFA14A
COEP Coeptis Therapeutics Inc.
17 May 22
Additional proxy soliciting materials
4:59pm
10-Q
2022 Q1
COEP Coeptis Therapeutics Inc.
12 May 22
Quarterly report
2:22pm
8-K
COEP Coeptis Therapeutics Inc.
19 Apr 22
Coeptis Therapeutics, Inc. and Bull Horn Holdings Corp. Announce Merger Agreement
4:51pm
8-K
COEP Coeptis Therapeutics Inc.
12 Apr 22
Entry into a Material Definitive Agreement
5:21pm
8-K
COEP Coeptis Therapeutics Inc.
5 Apr 22
Departure of Directors or Certain Officers
5:16pm
10-K
2021 FY
COEP Coeptis Therapeutics Inc.
11 Mar 22
Annual report
5:13pm
8-K
COEP Coeptis Therapeutics Inc.
25 Feb 22
Entry into a Material Definitive Agreement
10:53am
S-1
COEP Coeptis Therapeutics Inc.
3 Feb 22
IPO registration
7:00pm
8-K
COEP Coeptis Therapeutics Inc.
27 Dec 21
Entry into a Material Definitive Agreement
4:00pm
253G1
COEP Coeptis Therapeutics Inc.
6 Dec 21
Information omitted from offering circular
12:53pm
CORRESP
COEP Coeptis Therapeutics Inc.
30 Nov 21
Correspondence with SEC
7:00pm
UPLOAD
COEP Coeptis Therapeutics Inc.
23 Nov 21
Letter from SEC
7:00pm
4
David Mehalick
18 Nov 21
Coeptis Therapeutics / David Mehalick ownership change
2:00pm
1-A
COEP Coeptis Therapeutics Inc.
18 Nov 21
Offering $12M in Equity
12:44pm
10-Q
2021 Q3
COEP Coeptis Therapeutics Inc.
15 Nov 21
Quarterly report
3:45pm
D/A
COEP Coeptis Therapeutics Inc.
12 Oct 21
$9M in equity, sold $5.52M, 42 investors
7:52am
8-K
COEP Coeptis Therapeutics Inc.
30 Sep 21
Termination of a Material Definitive Agreement
8:00pm
8-K
COEP Coeptis Therapeutics Inc.
26 Aug 21
Termination of a Material Definitive Agreement
8:00pm
8-K
COEP Coeptis Therapeutics Inc.
19 Aug 21
Coeptis Therapeutics Partners with VyGen-Bio, Inc. to Co-develop Two Assets
12:53pm